Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid

 
• By Bridget Silverman

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

Keeping Track Feature image
Viltepso for certain DMD patients garnered the PRV for Nippon Shinyaku.

More from US FDA Performance Tracker

More from Regulatory Trackers